Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia.

Author: AlibertiEmilio, AnnunziataMario, BrescianiAlessandro, FortunatoGiuliana, GiacobbeCarola, IannuzziArcangelo, IannuzzoGabriella, PalmaDaniela

Paper Details 
Original Abstract of the Article :
PEG-Asparaginase (also known as Pegaspargase), along with glucocorticoids (predominantly prednisolone or dexamethasone) and other chemotherapeutic agents (such as cyclophosphamide, idarubicin, vincristine, cytarabine, methotrexate and 6-mercaptopurine) is the current standard treatment for acute lym...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882989/

データ提供:米国国立医学図書館(NLM)

PEG-Asparaginase: A Case of Drug-Induced Hypertriglyceridemia

Acute lymphoblastic leukaemia (ALL) is a serious cancer, and treatments like PEG-asparaginase are vital for fighting it. However, this case report highlights a potential side effect of PEG-asparaginase - severe hypertriglyceridemia, a condition characterized by high levels of triglycerides in the blood.

Genetic Susceptibility

This case report provides a valuable insight into the potential role of genetic factors in drug-induced hypertriglyceridemia. The patient's genetic analysis revealed a rare variant in the APOC3 gene, suggesting a possible predisposition to this side effect. Think of it like a genetic map, revealing certain individuals might be more vulnerable to specific drug reactions.

Personalized Treatment Strategies

This case report emphasizes the importance of personalized treatment strategies, taking into account individual genetic factors. It's a reminder that one size does not fit all when it comes to drug therapy.

Dr. Camel's Conclusion

This case report serves as a reminder that even seemingly safe medications can have unexpected side effects, and that genetic factors play a crucial role in determining individual responses to drugs. It's essential to be aware of these possibilities and to tailor treatment strategies to each patient's unique genetic profile.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-03-04
Further Info :

Pubmed ID

35237305

DOI: Digital Object Identifier

PMC8882989

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.